BioSpace News Archive

SparingVision, a clinical-stage genomic medicine company developing vision-saving treatments for ocular diseases, announces the appointment of Joseph C.

AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, will host a key opinion leader (KOL) webinar on early diagnosis and prevention of Alzheimer’s disease on Tuesday, April 18, 2023 at 10:30 AM EDT / 4:30 PM CEST.

Kraig Biocraft Laboratories, Inc., the biotechnology company focused on the development and commercialization of spider silk, announces that it is preparing a response to the United States Air Force under the Defense Production Act Investments program.

Tonix Pharmaceuticals Holding Corp. announced that two posters with research results on TNX-1700 will be presented as posters at the American Association for Cancer Research Annual Meeting being held April 14-19, 2023, in Orlando, Fla.

AlzeCure Pharma AB, a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the central nervous system, with projects in both Alzheimer’s disease and pain, announced that its Annual Report for 2022 has been published.

Addex Therapeutics Ltd announced that it has completed the equity financing transaction entered into on April 3, 2023 with a leading institutional healthcare investor, pursuant to which the Company sold 7,999,998 shares in the form of 1,333,333 American Depositary Shares at a gross purchase price of $0.95 per ADS.

Occlutech Holding AG, one of the world’s leading providers of minimally invasive structural heart disease devices, receives subscription commitment subject to certain conditions, of bonds to an aggregated amount of EUR 40 million.

Aurinia Pharmaceuticals Inc. announced promising results from the AURORA Renal Biopsy Sub-Study.